News 2019

Nordic Fertility Society Annual Congress (NFS 2019)


Come and see the Planer team at this year’s Nordic Fertility Society’s Annual Congress (NFS 2019). NFS 2019 will take place from Thursday 22nd August to Saturday 24th August in the Quality Hotel 11 Göteborg, Sweden.

Established in 1999, the Nordic Fertility Society’s membership includes, doctors, embryologists, biologists and laboratory technicians from five countries – Denmark, Finland, Iceland Norway and Sweden.

Product demo on Thursday 22nd August at 09.00
Planer is delighted to be exhibiting at NFS for the first time. If you are going to Goteborg, why not drop by the Planer stand on Thursday at 09.00 to watch Kalend from the Planer team demo our CT37stax™ benchtop incubator and DATAssure™, our independent monitoring and alarm system for laboratories.

For further information
Nordic Fertility Society (NFS) 2019 Congress
Nordic Fertility Society
Planer CT37stax™ benchtop incubator
DATAssure™ independent monitoring system

Come and see us at SLTB 2019

Society for Low Temperature Biology 2019 Conference

The Society for Low Temperature Biology (SLTB) will, this year, be holding their annual conference in the beautiful city of Seville from the 3rd to 4th October 2019.

Founded in 1964, the aim of the SLTB is to promote research into the effects of low temperatures on all types of organisms and their constituent cells, tissues and organs. These types of studies have applications in a diverse range of scientific fields; from biology and medicine to engineering, conservation and environmental science.

Planer is delighted to be supporting the 2019 Annual Conference, where specialists from around the world will be speaking on a range of cutting edge topics.

Before the meeting itself starts, there will be a cell therapy workshop on Wednesday 2nd October. Held in conjunction with the UK Stem Cell Users Group, the workshop will give attendees the opportunity to hear industry experts such as Alison Hubel, from the University of Minnesota, speak.

For further information
SLTB 2019
Society for Low Temperature Biology

Successful Course in Cryopreservation and Transplantation of Ovarian Tissue

UCL Ovarian Tissue Cryopreservation and Transplantation Course
The team from Université Catholique de Louvain (UCL) in Brussels, Belgium recently held a course on cryopreservation and transplantation of human ovarian tissue. The course, which was held on the 27th and 28th June 2019, was led by Christiani Amorim and the team from the university who have worked for many years on researching and developing the techniques required for successful cryopreservation and transplantation of ovarian tissue.

The course was attended by participants from clinical centres from all around the world proving this technique, despite still being considered experimental in some countries, is growing in popularity. The number of successful live births being recorded around the world continues to grow year on year as the technique has become more widely available.

The team at the University uses a Planer Kryo 360 -1.7 to perform the cryopreservation of the ovarian tissue as this has proven to provide consistent successful results. There are now many centres around the world that have reported the benefits of slow freezing when cryopreserving ovarian tissue and Planer are proud to be associated with this important technique that can result in many women going on to have children, sometimes naturally, even after cancer treatment.

Christiani and the team are already planning further courses including a one day workshop on Tuesday 24th September 2019 at the 12th Congress of the Pacific Society for Reproductive Medicine (PSRM) which is being held in Pattaya, Thailand  this year.

For further information
UCL Course on Cryopreservation and Transplantation of Human Ovarian Tissue (27th - 28th June 2019)
The 12th Congress of the Pacific Society for Reproductive Medicine (PSRM)
Planer Kryo 360 controlled rate freezer

New CT37stax™ benchtop incubator brochure available

CT37stax benchtop incubator brochureTake a look at our latest CT37stax™ brochure, which outlines some of the new additional features of our multi chamber benchtop incubator.

The CT37stax™ is a modular, space saving benchtop incubator that can be expanded as the needs of your laboratory grow. It is available initially with three to six incubator chambers. Additional chambers can be added to your system as demand expands*. The modular design reduces redundant unused dish spaces and therefore ensures this incubator is a long-term cost effective solution.

  • High capacity incubator using 30% less lab space
  • Accurate environmental controls providing the optimal clinical environment
  • Capacity for up to 36 patients
  • Compact modular design helps improve laboratory workflow
  • Individually controlled incubation chambers
  • All chambers individually monitored with audible and visible alarms

 *up to the maximum of six chambers in a single system

Monitor your CT37stax™ benchtop incubator, with our new PIMSsolo unit

CT37stax benchtop incubator

On display for the first time at ESHRE 2019 was the PIMSsolo user interface unit, which can be used alongside, or even mounted on, the CT37stax™ to enable clinics to control a single CT37stax™ system.

PIMSsolo unit clearly displays all the relevant parameters and messages from a single CT37stax™ system on a simple to use touchscreen display making day to day management of a CT37stax™ simple and convenient.

PIMSsolo will be available with a variety of different mounting options to allow users to choose the most convenient for their specific needs. Pictured here is the PIMSsolo unit mounted directly on a CT37stax™ system. Desktop and wall mounted versions will also be available.

For further information
Find out more about the CT37stax™
Download our latest CT37stax™ brochure

If you would like more information about our CT37stax™ benchtop incubator and our PIMSsolo unit, please get in touch with the sales team at Planer.

Air pollution reduces women's egg reserves

Shaoni Bhattacharya reports from the European Society for Human Reproduction and Embryology's 2019 annual meeting in Vienna

Exposure to environmental air pollutants may decrease a woman's ovarian reserve, suggests a new study.

'Living in an area associated with high levels of air pollutants in our study increased the risk of severely reduced ovarian reserve by a factor of two or three,' said Professor Antonio La Marca from the University of Modena and Reggio Emilia in Modena, Italy.

The researchers used a 'big data' approach to link hospital hormone measurements for more than 1300 Italian women in Modena with 'real-time' environmental data on levels of nitrogen dioxide and particulate matter from the regional authorities, along with geo-location data using Google Maps and the women's addresses.

The researchers used levels of anti-Müllerian hormone (AMH) as a marker of ovarian reserve, in women living in the urban area between 2007-2017.

As expected, AMH levels decreased with age, they were also inversely related to environmental pollutants released by the burning of fossil fuels, and this association was independent of age. Hormone levels indicating a severe reduction were more frequent at the highest levels of exposure. Richard Anderson, Professor of Clinical Reproductive Science at the University of Edinburgh called the study 'interesting and potentially important', he added: 'However this sort of study cannot clearly show cause and effect, and it might be another aspect of the women's lifestyle or environment that is the key factor.'

For further information:-
"Air pollution reduces women's egg reserves" - Shaoni Bhattacharya, Progress Educational Trust via IVF.net

New version of PetriSense® ST launched at ESHRE 2019

Our new and improved version of PetriSense® ST was launched at ESHRE 2019. This unique petri dish sized sensor can be used to easily validate CO2 and the related pH from up to two individual sensors placed inside an incubator.

The PetriSense® ST can be used with the majority of benchtop incubators available on the market. It requires no modification to the incubator and can quickly be moved from unit to unit, eliminating the need for multiple sensors.

PetriSense®ST software, which operates the sensor, provides configuration, calibration and monitoring applications for the product. The software can be downloaded directly from the Planer website and installed on your laboratory laptop or PC. Alternatively, the PetriSense®ST can be supplied with a 10 inch Windows touchscreen tablet.

For further information
PetriSense® ST - standalone monitoring of COand related monitoring of PH
What is virtual pH. An introduction to the new Petri dish pH / COsensor

 

No difference in IVF success between frozen or fresh embryos

Reporting from the European Society for Human Reproduction and Embryology's 2019 annual meeting in Vienna. Source: Shaoni Bhattacharya, Progress Educational Trust via IVF.net

Freezing embryos for later implantation or using them fresh makes no difference to the success of IVF, according to a new study.

The so-called 'freeze-all' strategy has become increasingly popular in many fertility clinics as frozen embryo transfer is thought to reduce the risk of Ovarian Hyperstimulation Syndrome (OHSS) and improve IVF outcomes generally. 

In the study, some 460 patients at eight clinics across Denmark, Sweden and Spain had a single blastocyst transferred for IVF. A freeze-all approach was used in one group, with the frozen embryo transferred in a subsequent cycle. Fresh embryos were transferred in the other group.

The ongoing pregnancy rate following transfer was similar with both methods, as was the number of babies born through each method.

For further information
Shaoni Bhattacharya, Progress Educational Trust via IVF.net

HFEA issues first commissioning guidance for fertility treatment

ivf
The UK Human Fertilisation and Embryology Authority (HFEA) has released new commissioning guidance offering NHS Clinical Commissioning Groups (CCGs) advice on delivering high-quality cost-effective fertility services.

Many CCGs have cut funding for IVF in recent years, and patient access to fertility services is inconsistent across the UK. The new guidance aims to standardise how much CCGs should spend per IVF cycle, to offer the best value to patients and to support provision of treatment in accordance with the recommendations of the National Institute for Health and Care Excellence (NICE): three full IVF cycles to women under 40 and one full cycle to women aged 40-42 without children. 

The HFEA worked with the British Fertility Society, Association of Clinical Embryologists, Royal College of Obstetricians and Gynaecologists and Royal College of Nursing to produce the guidance, which explains the positive impacts of commissioning fertility services, including the lower rates of reproductive tourism and reduced multiple pregnancies.

For further information
"HFEA issues first commissioning guidance for fertility treatment" BioNews 3rd June 2019

News Stories - 2019

News Stories - 2018

News Stories - 2017